Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2C | P18825 | 13/20 | 0.65 |
| ▸ | ADRA2A | P08913 | 12/20 | 0.65 |
| ▸ | ADRA2B | P18089 | 12/20 | 0.65 |
| ▸ | ADRA1A | P35348 | 5/20 | 0.65 |
| ▸ | ADRA1D | P25100 | 4/20 | 0.65 |
| ▸ | ADRA1B | P35368 | 4/20 | 0.65 |
| ▸ | LMNA | P02545 | 3/20 | 0.65 |
| ▸ | HTR1D | P28221 | 3/20 | 0.65 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.65 |
| ▸ | NISCH | Q9Y2I1 | 2/20 | 0.65 |
| ▸ | MEN1 | O00255 | 1/20 | 0.65 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.65 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.65 |
| ▸ | HTR1A | P08908 | 1/20 | 0.65 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.65 |
| ▸ | HRH2 | P25021 | 1/20 | 0.65 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.65 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Romifidine SCHEMBL29761110 | 0.89 | ADRA2C (0.56) | ADRA2CADRA2AADRA2BADRA1AADRA1D | |
| SCHEMBL9920135 | 0.89 | ADRA2A (0.79) | ADRA2CADRA2AADRA2BADRA1AADRA1D | |
| Romifidine SCHEMBL246009 | 0.89 | ADRA2C (0.56) | ADRA2CADRA2AADRA2BADRA1AADRA1D | |
| Romifidine SCHEMBL1970327 | 0.88 | ADRA2C (0.57) | ADRA2CADRA2AADRA2BADRA1AADRA1D | |
| Romifidine SCHEMBL22616284 | 0.88 | ADRA2C (0.55) | ADRA2CADRA2AADRA2BADRA1AADRA1D | |
| SCHEMBL8989304 | 0.86 | ADRA2A (0.54) | ADRA2CADRA2AADRA2BADRA1AADRA1D | |
| Romifidine SCHEMBL22616255 | 0.82 | ADRA2C (0.49) | ADRA2CADRA2AADRA2BADRA1AADRA1D | |
| Romifidine SCHEMBL22616210 | 0.82 | ADRA2C (0.49) | ADRA2CADRA2AADRA2BADRA1AADRA1D | |
| Romifidine SCHEMBL22616229 | 0.81 | ADRA2C (0.48) | ADRA2CADRA2AADRA2BADRA1AADRA1D | |
| Romifidine SCHEMBL22616310 | 0.80 | HTR1D (0.50) | ADRA2CADRA2AADRA2BADRA1AADRA1D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120149900-A1 | FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2012-06-14 | — | — | US | disclosed |
| WO-2010081034-A2 | FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2010-07-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120149900-A1 | FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF | FLI1, CDC73, FOS | ADRA2C 3370/4885ADRA2A 4623/4885ADRA2B 4201/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.